Knowledge Center

Article / Jan 01, 2012

Carcinogenic pollutants in drug manufacturing

Authors:
  • Gyorgy Szekely
  • William Heggie
  • Boerje Sellergren
Source:
Magyar Kemikusok Lapja (2012), 67(2), 34-37

A review.

Also in the Knowledge Center

Related Content

Enhanced process understanding

Ensuring enhanced understanding through state of the art methodologies and technologies.

Page
Read more

Continuous Tableting for Drug Product

Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.

Page
Read more

B Corporation

In 2017, Hovione became a Certified B Corp. The first Chemical/ Pharmaceutical Company integrating an innovative community of companies that use the power of business to solve social and environmental problems.

Page
Read more